Introduction
============

Acute pancreatitis (AP) is an inflammatory disease of exocrine pancreas with rapid onset, fast and uncontrollable progress, which ranges from self-limited disease to severer progressive disease with organ dysfunction and death ([@B1]). AP may develop into severe acute pancreatitis (SAP) that is associated with multiple organ failure and systemic inflammatory response syndrome (SIRS). The factors causing SAP are complex and closely related to bad living habits, gallstones, alcohol, etc. ([@B2]). It has the characteristics of critical illness, many complications and high fatality rate. Moreover, with the improvement of living standards, its incidence rate is increasing year by year ([@B3]). Although the vast majority of SAP patients can be cured without complications, as many as 25% of those hospitalized in ICU for 2 weeks, even after treatment, will suffer from serious complications or even death ([@B4], [@B5]). Therefore, early diagnosis and evaluation of SAP is of great significance for the treatment and prognosis of patients.

Acute physiology and chronic health evaluation II (APACHE II) evaluation system, lipase and amylase are commonly used in the clinical evaluation of AP patients. However, APACHE II evaluation system is relatively complex and is not easy to be widely applied. Lipase and amylase are lack of specificity in evaluating the severity of AP ([@B6], [@B7]). The prognosis of SAP patients depends on the degree of pancreatic necrosis and the severity of multiple system organ failure caused by systemic inflammatory response ([@B8]). Local tissue damage is closely related to the balance of inflammatory factors in SAP, so limiting inappropriate pro-inflammatory mediators in circulation is the key to patient recovery ([@B9]). C-reactive protein (CRP), a kind of inflammatory factor and a sensitive indicator for chronic inflammation diagnosis, is obviously increased in tissue damage and acute inflammation, being a marker reflecting inflammation ([@B10]). Procalcitonin (PCT) level is significantly increased in inflammation, infection, and organ failure, so it can be used as an evaluation index for infection ([@B11]). The main component of leukocytes in the peripheral blood of normal people is neutrophils, the ratio of which is significantly increased in inflammation and bacterial infection ([@B12]).

There are many studies on PCT, CRP and neutrophil ratio (N%) in SAP ([@B13]--[@B15]), but the diagnostic value of the combination of the three and its role in prognosis evaluation has been rarely studied. Therefore, in this study, PCT and CRP, and N% in peripheral blood of SAP patients were detected to explore their values in the diagnosis and prognosis evaluation of SAP.

Materials and Methods
=====================

General data
------------

The medical records of 104 patients with SAP (SAP group) and 101 patients with mild acute pancreatitis (MAP) (MAP group) admitted to our hospital from 2016 to 2019 were recruited in this study. There were 63 males and 41 females in the SAP group, aged 27--81 years with an average age of (59.7±8.9) years. Whereas in the MAP group, there were 58 males and 43 females, aged 26--79 years with an average age of (58.3±8.2) years. Inclusion criteria: SAP and MAP meeting the clinical validation of revised 2012 Atlanta Classification, USA ([@B16]); pancreatitis confirmed by MRI and CT imaging; patients with typical abdominal distension and abdominal pain symptoms; serum amylase ≥3 times the upper limit of normal standard; all patients admitted to hospital within 24 hours of onset and receiving symptomatic treatment within 48 hours; patients with complete clinical data. Exclusion criteria: patients who used anti-inflammatory and immunosuppressive drugs in the past month; patients who died within 7 days of admission; patients complicated with rheumatic diseases, other surgical acute abdomen, chronic inflammatory diseases, other acute infectious diseases, coronary heart disease, malignant tumors, severe trauma, tuberculosis and neuropsychiatric diseases.

The study was approved by the Ethics Committee of our hospital. The subjects and their guardians were informed and signed fully informed consent forms.

Treatment methods
-----------------

After admission, all patients were given conventional symptomatic treatment ([@B17]), including gastrointestinal decompression, antacid, amylase inhibition, fasting, circulation improvement, maintenance of water and electrolyte and acid-base balance, and antibiotics when necessary. Important organ functions were strictly monitored and fluid resuscitation were carried out actively. Pancreatic imaging examination was performed on admission, and 3rd, 5th and 7th day of admission, and symptomatic treatment was performed on problems found.

Outcome measures
----------------

Fasting peripheral blood (3mL) was drawn from the patients at the time of admission and placed in vacuum tubes without anticoagulant and anticoagulant tubes containing Ethylenediamine tetraacetic acid-K2 (EDTA-K2). Next, the blood was centrifuged for 10min with a radius of 10cm and a centrifugal force of 1450(×g) to separate the serum. The CRP and PCT (Chundu Biotechnology Co., Ltd., Wuhan, China, batch no: CDJ-1296C-SJH, CD-0208-LIN) in the serum were detected with Johnson Vitros5600 automatic biochemical-immune analyzer (Johnson & Johnson clinical diagnostics, Inc., NY, USA). The operations were carried out in strict accordance with the instruction manual of the instrument and kit. DxH 800 hematology analyzer (Beckman Coulter, Chaska, MN, USA) was used to measure N% in peripheral blood. These indexes of patients in the SAP group were repeatedly detected on the 3rd, 5th and 7th day of admission. Normal CRP: 0--8 mg/L ([@B18]); normal PCT: 0--0.05 ng/ml ([@B19]); Normal N%: 60--75% ([@B20]).

Statistical methods
-------------------

SPSS 20.0 (IBM Corp, Armonk, NY, USA) was used for statistical analysis, and GraphPad Prism 6 was used to plot the figures. The counting data were expressed by the number of cases/percentage \[N(%)\] and the chi-square test was used for comparison between groups. Measurement data accorded with normal distribution were expressed by mean±standard deviation (x¯±SD) and independent samples *t*-test was used for the comparison between groups. Measurement data not accorded with normal distribution were expressed by M (P25, P75) and Mann-Whitney U test was used for the comparison between groups. The data between different time points were compared by repeated measures analysis of variance (ANOVA), and Bonferroni method was used for pairwise comparison between different time points in the group. The receiver operating characteristic (ROC) curve was plotted and the optimal Youden index-based cutoff point was selected to evaluate the diagnostic value of CRP, PCT, and N% in SAP, and to determine their area under curve (AUC), sensitivity, and specificity. The difference was statistically significant with *P* \< 0.05.

Results
=======

Baseline data
-------------

There was no significant difference between the SAP group and the MAP group in sex, age, body mass index (BMI), smoking and drinking history, diabetes mellitus, pathogenic factors, blood and urine amylase, platelet, leukocyte, total cholesterol (TC), high density lipoprotein (HDL), blood urea nitrogen (BUN), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (TB), while there were significant differences in APACHE-II score and Ranson score (*P* \< 0.001) ([Table 1](#T1){ref-type="table"}).

###### 

Baseline data in SAP group and MAP group \[n(%)\]/(x¯±SD)

  ***Classification***   ***SAP group (n=104)***      ***MAP group (n=101)***      **Z/t/*χ^2^***   **P**
  ---------------------- ---------------------------- ---------------------------- ---------------- ---------
  Sex                                                                              0.210            0.647
  Male                   63 (60.58)                   58 (57.43)                                    
  Female                 41 (39.42)                   43 (42.57)                                    
  Age (years)            59.7±8.9                     59.7±8.9                     1.170            0.243
  BMI (kg/m^2^)          22.84±2.14                   22.76±2.19                   0.264            0.792
  Smoking history                                                                  0.371            0.542
  Yes                    44 (42.31)                   47 (46.53)                                    
  No                     60 (57.69)                   54 (53.47)                                    
  Drinking history                                                                 0.358            0.550
  Yes                    46 (44.23)                   50 (49.50)                                    
  No                     58 (55.77)                   51 (50.50)                                    
  Diabetes mellitus                                                                3.185            0.074
  Yes                    22 (21.15)                   12 (11.88)                                    
  No                     82 (78.85)                   89 (88.12)                                    
  APACHE-II score        10.8±3.2                     6.9±3.1                      8.859            \<0.001
  Ranson score           2.0±0.7                      1.6±0.9                      3.558            \<0.001
  Pathogenic factors                                                               3.524            0.620
  Cholecystolithiasis    40 (38.46)                   35 (34.65)                                    
  Choledocholithiasis    11 (10.58)                   10 (9.90)                                     
  Overeating             4 (3.85)                     2 (1.99)                                      
  Cholecystitis          14 (13.46)                   23 (22.77)                                    
  Alcoholic              26 (25.00)                   24 (23.76)                                    
  Hyperlipemia           9 (8.65)                     7 (6.93)                                      
  Blood amylase (U/L)    977.89 (510.36--1663.16)     967.20 (535.56--1433.15)     −0.403           0.687
  Urine amylase (U/L)    2798.40 (1426.59--4024.48)   2404.20 (1067.02--4010.66)   −1.286           0.199
  Platelet (×10^9^/L)    150.18 (108.06--194.77)      152.80 (112.49--184.81)      −0.291           0.771
  Leukocyte (×10^9^/L)   15.83±5.94                   15.23±4.74                   0.798            0.426
  TC (mmol/L)            3.21±1.02                    3.34±1.35                    0.779            0.437
  HDL (mg/L)             0.91±0.38                    0.89±0.22                    0.459            0.646
  BUN (mmol/L)           13.64 (6.70--19.38)          12.04 (7.53--15.72)          −1.308           0.191
  ALT (U/L)              55.01 (30.92--83.99)         55.71 (39.16--74.48)         −0.148           0.882
  AST (U/L)              80.48 (50.46--122.34)        78.48 (49.57--110.28)        −0.820           0.412
  TB (μmol/L)            45.44 (79.80--62.20)         41.07 (28.86--53.26)         −1.717           0.086

PCT, CRP, and N% in peripheral blood
------------------------------------

The detection showed that the PCT, CRP, and N% in the SAP group were significantly higher than those in the MAP group (*P* \< 0.001). Taking baseline data and serological indicators as independent variables, and SAP as a dependent variable, multivariate Logistic regression analysis showed that APACHE II score (*P*=0.001), Ranson score (*P*=0.012), PCT (*P*=0.012), CRP (*P*=0.001), and N% (*P*=0.001) were independent risk factors for SAP ([Table 2](#T2){ref-type="table"}--[3](#T3){ref-type="table"}).

###### 

Comparison of peripheral blood PCT, CRP, and N% (x¯±SD)

  ***Group***   ***n***   ***PCT (ng/mL)***   ***CRP (mg/L)***   ***N%***
  ------------- --------- ------------------- ------------------ ------------
  SAP group     104       1.99±0.25           53.27±16.16        86.09±0.68
  MAP group     101       1.56±0.21           32.44±11.68        85.03±0.78
  *t*           \-        13.650              10.560             10.380
  *P*           \-        \<0.001             \<0.001            \<0.001

###### 

Multvariate Logistic regression analysis of SAP

  ***Variable***     ***B***   ***S.E***   ***Wals***   ***P***   ***OR***   ***95% CI***
  ------------------ --------- ----------- ------------ --------- ---------- ---------------
  APACH E-II score   0.291     0.071       16.799       0.001     1.338      1.164--1.538
  Ranson score       0.651     0.259       6.315        0.012     1.917      1.154--3.184
  PCT (ng/mL)        1.929     0.764       6.383        0.012     6.883      1.541--30.743
  CRP (mg/L)         0.128     0.024       28.520       0.001     1.136      1.084--1.191
  N%                 2.290     0.474       23.375       0.001     9.873      3.902--24.978

Diagnostic value of PCT, CRP, and N% in SAP
-------------------------------------------

The ROC curves of peripheral blood PCT, CRP, and N% in diagnosing SAP were plotted. The AUC, cut-off, sensitivity, and specificity of PCT were 0.906, 1.80ng/mL, 84.62%, and 89.11% respectively, those of CRP were 0.840, 51.38mg/L, 60.58%, and 93.07%, and those of N% were 0.834, 85.52%, 80.77%, and 73.27% respectively. Using PCT, CRP, and N% as independent variables, a Logistic regression model was obtained: Logit (P) =−207.022+6.945 PCT+0.090 CRP+2.235 N%. The AUC, sensitivity, and specificity of combined detection of PCT, CRP, and N% in diagnosing SAP were 0.972, 91.35%, and 91.09% respectively ([Table 4](#T4){ref-type="table"} and [Fig. 1](#F1){ref-type="fig"}).

![ROC curves of peripheral blood PCT (A), CRP (B), N% (C), and their combination (D) in diagnosing SAP](IJPH-48-2177-g001){#F1}

###### 

Diagnostic value of PCT, CRP, and N% in SAP

  ***Index***   ***AUC***   ***95%CI***    ***Std. Error***   ***Cut-off***   ***Sensitivity (%)***   ***Specificity (%)***
  ------------- ----------- -------------- ------------------ --------------- ----------------------- -----------------------
  PCT (ng/mL)   0.906       0.863--0.948   0.022              1.80            84.62                   89.11
  CRP (mg/L)    0.840       0.786--0.893   0.027              51.38           60.58                   93.07
  N%            0.834       0.779--0.889   0.028              85.52           80.77                   73.27
  PCT+CRP+N%    0.972       0.954--0.990   0.009              0.48            91.35                   91.09

Correlation of PCT, CRP, and N% with APACHE-II score and Ranson score in SAP
----------------------------------------------------------------------------

Pearson correlation coefficient showed that PCT, CRP, and N% were positively correlated with APACHE-II score and Ranson score (*P*\< 0.001) ([Fig. 2](#F2){ref-type="fig"}).

![Correlations of PCT, CRP, and N% with APACHE-II score and Ranson score in SAP. PCT (A), CRP (B), and N% (C) were positively correlated with APACHE-II scor. PCT (D), CRP(E), and N% (F) were positively correlated with Ranson score](IJPH-48-2177-g002){#F2}

Changes of PCT, CRP and N% at different time points after admission
-------------------------------------------------------------------

Of 104 patients with SAP, 92 were cured, and 12 died, while all of 101 patients with MAP were cured and discharged from hospital. Repeated measures ANOVA showed that there were significant differences in peripheral blood PCT, CRP, and N% between survivors and deaths at different time points (*P*\< 0.001). PCT, CRP and N% in deaths were significantly higher than those in survivors at different time points (*P*\<0.05). PCT and N% showed the most obvious difference on the 7th day of admission, while CRP on the 3rd day ([Fig. 3](#F3){ref-type="fig"}).

![Changes of peripheral blood PCT (A), CRP (B) and N% (C) at different time points after admission](IJPH-48-2177-g003){#F3}

Diagnostic value of PCT, CRP, and N% in the prognosis of SAP
------------------------------------------------------------

ROC curves, with the most obvious statistical difference within 7 days of admission, of PCT, CRP and N% in diagnosing SAP death were plotted. The AUC, cut-off, sensitivity and specificity of PCT were 0.907, 5.52ng/mL, 83.33% and 97.85% respectively, those of CRP were 0.900, 165.30mg/L, 91.67% and 78.26%, and those of N% were 0.894, 87.27%, 91.67% and 83.70% respectively ([Table 5](#T5){ref-type="table"} and [Fig. 4](#F4){ref-type="fig"}).

![ROC curves of peripheral blood PCT (A), CRP (B), and N% (C) in diagnosing SAP death](IJPH-48-2177-g004){#F4}

###### 

Diagnostic value of PCT, CRP, and N% in SAP death

  ***Index***   ***AUC***   ***95%CI***    ***Std. Error***   ***Cut-off***   ***Sensitivity (%)***   ***Specificity (%)***
  ------------- ----------- -------------- ------------------ --------------- ----------------------- -----------------------
  PCT (ng/mL)   0.907       0.765--1.050   0.073              5.52            83.33                   97.85
  CRP (mg/L)    0.900       0.812--0.987   0.045              165.30          91.67                   78.26
  N%            0.894       0.803--0.984   0.046              87.27           91.67                   83.70

Discussion
==========

SAP, a common clinical critical illness with an increasing incidence, has become one of the factors threatening human health ([@B21]). Its pathogenesis is considered to be pathological changes of abnormal activated pancreatins that induce monocytes and macrophages to release inflammatory mediators, thus damaging various organs and inducing SIRS ([@B22]). The vast majority of SAP patients suffer from necrotizing pancreatitis, and are easily complicated with infection, organ dysfunction, and even death in severe cases ([@B23]).

In this study, the PCT, CRP, and N% in the SAP group were significantly higher than those in the MAP group. Logistic regression analysis showed that APACHE II score, Ranson score, PCT, CRP, and N% were independent risk factors for SAP. Therefore, high PCT, CRP, and N% levels increase the risk of SAP. Previous studies have confirmed that APACHE-II score and Ranson score are useful tools for evaluating the severity and prognosis of AP ([@B24], [@B25]). Pearson correlation coefficient showed that PCT, CRP, and N% were positively correlated with APACHE-II score and Ranson score, suggesting that they are expected to be markers for the evaluation of SAP. ROC curves showed that the AUC of PCT, CRP, and N% in diagnosing SAP were 0.906, 0.840, and 0.834, respectively, indicating that they had good diagnostic value for SAP. In the research of Dias et al., plasma PCT and CRP levels were related to the total white blood cell count, as well as the ICU stay and the progress of SAP. During antibiotic treatment, The sensitivity and specificity of PCT were higher in diagnosing SAP when cut-off \> 2 ng/mL, while those of CRP were 70% and 65% respectively when cut-off \> 19 mg/dL ([@B26]). In this study, the optimal cut-off of PCT and CRP was 1.80 ng/mL and 51.38 mg/L respectively. It may be that we detected PCT and CRP in patients with SAP at admission, leading to the different cut-off, sensitivity and specificity. The ROC curve showed that the AUC of combined diagnosis of PCT, CRP, and N% in SAP was 0.972, which indicated that combined detection of the three improved their diagnostic efficiency for SAP. A study has revealed that interleukin-6 (IL-6), IL-8 and other inflammatory factors are indicators to evaluate the severity of early AP ([@B27]). Previous studies have confirmed that PCT, CRP, and N% are systemic inflammatory response markers ([@B28], [@B29]). The pathophysiological process of AP is excessive release of inflammatory cytokines and inflammatory transmitters, resulting in severe local tissue damage and systemic inflammation ([@B30]). PCT, CRP, and N% may therefore be involved in the course of the AP.

According to a study, inflammatory cytokines measured on admission and CRP measured on the 3rd day of admission could predict systemic complications in patients with AP ([@B31]). IL-6 and CRP contributed to early prediction and severity assessment of AP ([@B32]). However, there is no single indicator for death monitoring in patients with SAP. We observed the changes of PCT, CRP, and N% in peripheral blood within 7 days, and the results showed that the PCT, CRP, and N% in the deaths were significantly higher than those in survivors at different time points, which indicated that observation of PCT, CRP and N% in peripheral blood was helpful to monitor the prognosis of SAP patients. In Rau et al's study, monitoring PCT could evaluate the overall prognosis of AP patients with pancreatic infection and SAP patients ([@B33]). CRP level of SAP patients reached a peak at 48h after admission, then gradually decreased with time ([@B34]). Neutrophillymphocyte ratio could predict the severity of AP and was a risk factor for ICU admission and hospital stay of patients ([@B35]). Therefore, PCT, CRP and N% may play important roles in the poor prognosis of SAP, but diagnostic value of them in the SAP death has hardly been studied. The ROC curves of peripheral blood PCT, CRP, and N% in diagnosing SAP death was assessed. Time points with the most statistical difference between the survivors and the deaths were selected. The AUC of CRP in diagnosing SAP death was 0.900 on the 3rd day of admission, while that of PCT and N% was 0.907 and 0.894 respectively on the 7th day. Therefore, detection of PCT, CRP, and N% has good predictive value for poor prognosis of SAP patients.

However, there are still some deficiencies in our study. Firstly, the correlation of PCT, CRP and N% with organ failure and infection in patients with SAP is not explored. Secondly, the risk factors for prognosis (organ failure, infection, death) in patients with SAP are not analyzed. The above deficiencies will be addressed in future studies in order to further support the research conclusion.

Conclusion
==========

Peripheral blood PCT, CRP and N% contribute to the diagnosis and prognosis of SAP.
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